In connection with the deal, Assertio has divested the rest of its assets to New Jersey generics and branded drugmaker ...

AbbVie is spearheading a new battle in pharma's long-running fight to reform the federal government’s 340B drug discount ...

Robert F. Kennedy Jr. is starting a podcast. Unveiling the show on social media, the Department of Health and Human Services ...

After more than a decade in charge of the most influential organization representing the U.S. pharmaceutical industry, the ...

Pfizer is making more changes to its layout in California by stepping away from a South San Francisco office site that used ...

With another year of double-digit revenue growth in the books, Amgen’s longtime helmsman Robert Bradway continues to sit ...

Biogen has forged a settlement with investors who claimed the company misled them in describing how it gained a controversial ...

Japan’s Shionogi is joining the spate of drugmakers to announce manufacturing commitments in the U.S. since last year, albeit ...

Cognito Therapeutics is partnering with a nonprofit to “Change the D-Word,” aiming to eliminate the use of “dementia,” a ...

Johnson & Johnson’s immunology drug Tremfya is looking to challenge AbbVie’s dominance in 2026, securing the top spot as the ...

U.S. Olympic gold medal-winning athlete Lindsey Vonn is once again teaming up with infectious disease biopharma Invivyd for a ...

Among the measures ImmunityBio has implemented are “expanded promotional review protocols,” executive training and external ...